Current Allergy and Asthma Reports

, Volume 7, Issue 4, pp 285–292

Immunology of multiple sclerosis


DOI: 10.1007/s11882-007-0043-x

Cite this article as:
Pender, M.P. & Greer, J.M. Curr Allergy Asthma Rep (2007) 7: 285. doi:10.1007/s11882-007-0043-x


Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) leading to demyelination, axonal damage, and progressive neurologic disability. The development of MS is influenced by environmental factors, particularly the Epstein-Barr virus (EBV), and genetic factors, which include specific HLA types, particularly DRB1*1501-DQA1*0102-DQB1*0602, and a predisposition to autoimmunity in general. MS patients have increased circulating T-cell and antibody reactivity to myelin proteins and gangliosides. It is proposed that the role of EBV is to infect autoreactive B cells that then seed the CNS and promote the survival of autoreactive T cells there. It is also proposed that the clinical attacks of relapsing-remitting MS are orchestrated by myelin-reactive T cells entering the white matter of the CNS from the blood, and that the progressive disability in primary and secondary progressive MS is caused by the action of autoantibodies produced in the CNS by meningeal lymphoid follicles with germinal centers.

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Neuroimmunology Research Centre, Clinical Sciences BuildingRoyal Brisbane and Women’s HospitalHerstonAustralia